Superior Capsular Reconstruction vs. Partial Repair for Massive Rotator Cuff Tears
SCR
Arthroscopic Partial Repair vs. Superior Capsular Reconstruction for Massive Irreparable Rotator Cuff Tears: A Pilot Randomized and Controlled Trial
1 other identifier
interventional
70
1 country
2
Brief Summary
Little evidence exists to guide treatment in patients with massive irreparable rotator cuff tears (MRCTS). Arthroscopic partial rotator cuff repair (PRCR) has the longest record of use. The new technique of superior capsular reconstruction (SCR) has more recently been described. Despite high enthusiasm for this technique, its effectiveness, cost and safety profile have not been established. The long-term goal of this study is to perform a multicenter randomized control trial to evaluate the effectiveness of SCR compared to PRCR in patients with MRCTS. The current study is a pilot required to support the development of an expanded formal clinical trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2018
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 7, 2018
CompletedStudy Start
First participant enrolled
July 18, 2018
CompletedFirst Posted
Study publicly available on registry
August 6, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2028
September 19, 2024
August 1, 2024
8 years
May 7, 2018
September 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The American Shoulder and Elbow Surgeons Shoulder Score (ASES)
Functional Outcome Score Sub scales: Pain (10 cm VAS); function/disability (10 items, each rated on 4-point Likert scale for level of difficulty) Score range: Pain subscale 0-50 ASES points; function/disability subscale 0-50 ASES points. Total score 0-100 ASES points (0 = worse pain and functional loss/disability)
1 year post operative
Secondary Outcomes (12)
Complication rate
1 year post operative
Recruitment rate
1 year post operative
Constant-Murley Score
1 year post operative
Western Ontario Rotator Cuff Index
1 year post operative
Pain: Numeric Rating Scale
1 year post operative
- +7 more secondary outcomes
Study Arms (2)
Superior Capsular Reconstruction
EXPERIMENTALPatients will be treated with the new technique of superior capsular reconstruction with dermal allograft.
Partial Repair
ACTIVE COMPARATORPatients will have a partial repair with residual defect as an established standard procedure.
Interventions
Residual rotator cuff defect is reconstructed with a dermal allograft secured to the glenoid and humeral head.
Eligibility Criteria
You may qualify if:
- Symptomatic shoulder pain and/ or weakness (regardless of baseline range of motion/ psuedoparalysis)
- Massive rotator cuff tear, identified by MRI as being greater than 4 cm in greatest diameter, and involvement of the entire supraspinatus and infraspinatus.
- Failure of at least a 3 month trial of non-surgical treatment including physiotherapy and activity modifications
- Irreparable tear determined intra-operatively using standard arthroscopic techniques
- Informed consent obtained
You may not qualify if:
- Absence of subscapularis muscle insertion, or irreparable subscapularis tear
- Advanced rotator cuff tear arthropathy (Hamada Grade 3+) or glenohumeral osteoarthritis (Samilson-Prieto grade 2+)
- Acute tears (within 6 months)
- Neurologic injury causing paralysis of affected shoulder / arm
- Any previous surgery to the affected shoulder
- Limited life expectancy due to significant medical co-morbidity or medical contraindication to surgery (ASA Grade IV or higher)
- Anticipated problems with ability to maintain follow-up in the judgement of the investigators (ie. patients with no fixed address, etc.)
- Are there any non-orthopedic comorbidities that put the patient at significant risk?
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sunnybrook Health Sciences Centrelead
- Women's College Hospitalcollaborator
- St. Joseph's Healthcare Hamiltoncollaborator
- The Ottawa Hospitalcollaborator
Study Sites (2)
Sunnybrook Holland Orthopaedic & Arthritic Centre
Toronto, Ontario, M4Y 1H1, Canada
Women's College Hospital
Toronto, Ontario, M5S 1B2, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Patrick Henry, MD, FRCSC
Sunnybrook Health Sciences
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 7, 2018
First Posted
August 6, 2018
Study Start
July 18, 2018
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
July 1, 2028
Last Updated
September 19, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share